IMAC Holdings, Inc.

IMAC Holdings, Inc.

IMAC
IMAC Holdings, Inc.US flagNASDAQ Capital Market
1.01
USD
+0.02
- -
33.08MMarket Cap
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChat
CEO
Jeffrey S. Ervin
Full Time Employees
154
Sector
Healthcare
Industry
Medical - Care Facilities
Address
1605 Westgate Cir Brentwood TN United States of America 37027
IPO Date
Feb 13, 2019
Business
IMAC Holdings, Inc. provides proteomic products and precision medicine services based on activated protein analysis for cancer treatment through its subsidiary Ignite Proteomics LLC in the United States; the company offers a reverse phase protein array (RPPA) platform that quantifies protein signaling to support oncology clinical treatment decisions and biopharmaceutical drug development. Founded in 2000 and headquartered in Franklin, Tennessee, IMAC Holdings operates within the biotechnology sector, targeting oncologists, cancer patients, and pharmaceutical developers. Recent developments include the May 2024 acquisition of Theralink Technologies' assets to advance precision medicine in breast cancer diagnostics, a November 2024 $3.74 million PIPE financing via Series G convertible preferred stock and warrants plus a $60 million equity line, board expansions with oncology experts Peter Beitsch and Matthew Schwartz in 2024 alongside Jeffrey Busch as chairman, and Ignite Proteomics' February 2025 acquisition of PLA Code 0249U for advanced proteomic breast cancer assays.

Company News

APIChat
  • IMAC Holdings Introduces Ignite Proteomics: A New Standard for Matching Patients with the Right Cancer Therapies

  • IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q

  • IMAC Holdings Granted Extension by Nasdaq to Regain Compliance with Listing Rule 5250(c)(1)

  • Best Penny Stocks To Buy? Einhorn, Lynch, Cohen & Dalio Own These 5

  • Legendary Investor Peter Lynch Just Bet on IMAC Stock. 9 Things to Know.

  • Time to Take Profits on IMAC Stock After Shares Soar on Walmart News

  • Best Reddit Penny Stocks To Buy Now? 5 Trending Stocks To Watch Today

  • Will IMAC Holdings, Inc. (IMAC) Report Negative Q2 Earnings? What You Should Know

  • IMAC Holdings to Present at the Summer Solstice - Best Ideas from the Buy Side Conference on Tuesday, June 1, 2021

  • IMAC Holdings Announces Pricing of its Public Offering of Common Stock

  • IMAC Holdings Reports 2020 Financial Results and Corporate Update

  • IMAC Holdings, Inc. Announces Completion of First Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson's Disease

  • IMAC Holdings Adds Regenerative Wound Care Service in Regeneration Centers

  • 5 Stocks to Buy Now Trading Under $10 With Mammoth Upside Potential

  • IMAC Holdings Celebrates One-Year Anniversary of Health Maintenance Plans Surpassing 1,000 Members and Demonstrating Increased Demand for Spinal Wellness Among Its IMAC Regeneration Center Customers

  • IMAC Holdings Expands Florida Presence to Orlando Following Acquisition of Synergy Healthcare

  • IMAC Stock Price Increases 23.97%: Why It Happened

  • IMAC Holdings Completes First Infusion of Stem Cells in Clinical Study for the Treatment of Bradykinesia Due to Parkinson's Disease

  • IMAC Holdings Receives Forgiveness of $1.69 Million PPP Loan

  • IMAC Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement